Royalty Pharma plc (RPRX) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Current Price
$47.43
Price Target
$49.40
Target Range
$42.00 — $61.00
Analyst Rating
Buy
Forward P/E9.8x
Trailing P/E26.6x
Forward PEG—
Implied Growth+255.8%
Median Target$49.00
Analyst Spread38.5%
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$42
-11.4%
Consensus
$49
+4.2%
Bull Case
$61
+28.6%
Valuation Model TargetsConfidence: 30/100
Bear$10
Base$60
Bull$116
RPRX Price Target Analysis
Updated March 5, 2026As of March 5, 2026, Royalty Pharma plc (RPRX) has a Wall Street consensus price target of $49.40, based on estimates from 11 covering analysts. With the stock currently trading at $47.43, this represents a potential upside of +4.2%. The company has a market capitalization of $26.77B.
Analyst price targets range from a low of $42.00 to a high of $61.00, representing a 38% spread in expectations. The median target of $49.00 aligns closely with the consensus average.
The current analyst consensus rating is Buy, with 10 analysts rating the stock as a Buy or Strong Buy,1 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, RPRX trades at a trailing P/E of 26.6x and forward P/E of 9.8x. Analysts expect EPS to grow +255.8% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $60.16, with bear and bull scenarios of $10.04 and $116.13 respectively. Model confidence stands at 30/100, suggesting limited visibility into future performance.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+93.8%
Avg Forward P/E24.9x
Peers with Coverage5 / 8
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
| RPRXRoyalty Pharma plc | $26.8B | $47.43 | $49.40 | +4.2% | Buy | 9.8x | 11 |
 LGNDLigand Pharmaceuticals Incorporated | $4.1B | $208.95 | $248.00 | +18.7% | Buy | 24.6x | 16 |
 INVAInnoviva, Inc. | $1.7B | $22.73 | $32.50 | +43.0% | Buy | 11.5x | 10 |
 BTXBlackRock Technology and Private Equity Term Trust | $773M | $6.62 | — | — | — | — | — |
 XOMAPXOMA Corporation | $317M | $25.77 | — | — | Buy | 38.7x | 9 |
 XOMAXOMA Royalty Corp. | $316M | $26.45 | $68.25 | +158.0% | Buy | 39.7x | 10 |
 CBUSCibus, Inc. | $99M | $3.33 | $11.50 | +245.3% | Buy | — | 3 |
 CDTCDT Equity Inc. | $1M | $0.71 | — | — | — | — | — |
Upside Potential Comparison
CBUSXOMAINVALGNDRPRXSee RPRX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs RPRX Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare RPRX vs LLY
See how RPRX stacks up against sector leader Eli Lilly and Company.
Start ComparisonFrequently Asked Questions
What is the RPRX stock price target for 2026?
The consensus price target for RPRX is $49.4, close to the current price of $47.43 (4.2% implied move). Based on 11 analyst estimates, the stock appears fairly valued near current levels.
Is RPRX a buy, sell, or hold?
RPRX has a consensus rating of "Buy" based on 11 Wall Street analysts. The rating breakdown is predominantly bullish, with 10 Buy/Strong Buy ratings. The consensus 12-month price target of $49.4 implies 4.2% upside from current levels.
Is RPRX stock overvalued or undervalued?
With a forward P/E of 9.7514x, RPRX trades at a relatively low valuation. The consensus target of $49.4 implies 4.2% appreciation, suggesting the market may be pricing in risks.
How high can RPRX stock go?
The most bullish Wall Street analyst has a price target of $61 for RPRX, while the most conservative target is $42. The consensus of $49.4 represents the median expectation. Our quantitative valuation model projects a bull case target of $116 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
How many analysts cover RPRX stock?
RPRX is moderately covered, with 11 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 10 have Buy ratings, 1 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the RPRX stock forecast?
The 12-month RPRX stock forecast based on 11 Wall Street analysts shows a consensus price target of $49.4, with estimates ranging from $42 (bear case) to $61 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $60, with bear/bull scenarios of $10/$116.
What is RPRX's fair value based on fundamentals?
Our quantitative valuation model calculates RPRX's fair value at $60 (base case), with a bear case of $10 and bull case of $116. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 30/100.
What is RPRX's forward P/E ratio?
RPRX trades at a forward P/E ratio of 9.8x based on next-twelve-months earnings estimates compared to a trailing P/E of 26.6x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy RPRX stock?
RPRX appears fairly valued according to analysts, with a "Buy" rating and minimal upside to the $49.4 target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do RPRX price targets vary so much?
RPRX analyst price targets range from $42 to $61, a 38% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $49.4 consensus represents the middle ground. Our model's $10-$116 range provides an independent fundamental perspective.